NWBO — NORTHWEST BIOTHERAPEUTICS INC
—
OTC ·
Health Care ·
Pharmaceuticals ·
CIK 1072379 ·
Last close
$0.20
Market Cap
$328.67M
52W High
$0.30
52W Low
$0.18
ADV30
3,414,200
Next earnings
2026-08-13
Quarterly Fundamentals
Revenues vs Net Income (last 4 Q)
Assets vs Liabilities (last 4 Q)
| Period | Revenues | GrossProfit | OpIncome | NetIncome | Assets | Cash | Liabilities |
|---|---|---|---|---|---|---|---|
| Mar 2026 | 494,000 | — | -10,900,000 | -3,069,000 | 80,051,000 | 1,786,000 | 130,595,000 |
| Dec 2025 | 672,000 | — | -13,504,000 | 1,388,000 | 81,290,000 | 3,040,000 | 141,570,000 |
| Sep 2025 | 200,000 | — | -14,320,000 | -26,829,000 | 30,609,000 | 4,560,000 | 139,257,000 |
| Jun 2025 | 131,000 | — | -14,779,000 | -15,378,000 | 29,547,000 | 4,316,000 | 129,936,000 |
Cashflow TTM (yfinance, fills SEC gap)
Operating CF
$-47,854,000
Investing CF
$-1,851,000
Financing CF
$46,803,000
CapEx
$-1,540,000
Dividends Paid
—
Buybacks
—
EPS Diluted TTM
$-0.04
As of
2026-06-07
Balance + Analyst (yfinance extras)
Retained Earnings
$-1,506,730,000
Inventory
—
Receivables
$0
ST Investments
—
EBIT TTM
$-34,986,000
Pretax Income TTM
$-44,425,000
Interest Exp TTM
$9,439,000
Analysts
1
Yahoo Snapshot (yfinance, live)
Total Revenue
$1,497,000
EBITDA
$-51,102,000
Free Cash Flow
$-36,918,752
Enterprise Value
$404,149,568
Total Cash
$1,786,000
Total Debt
$63,994,000
Shares Out
1,643,343,757
Trailing EPS
$-0.03
Book Value
$-0.03
ROE
—
ROA
-62.2%
Div Yield
—
Annual Trend (SEC EDGAR, last 4y)
Revenues vs Net Income (last 4y)
| FY end | Revenues | OpIncome | NetIncome | Assets | Liabilities | Equity | OCF |
|---|---|---|---|---|---|---|---|
| Dec 2025 | 1,378,000 | -59,914,000 | -60,162,000 | 81,290,000 | 141,570,000 | — | -44,763,000 |
| Dec 2024 | 1,382,000 | -66,508,000 | -83,778,000 | 26,728,000 | 121,215,000 | — | -57,017,000 |
| Dec 2023 | 1,932,000 | -55,508,000 | -62,599,000 | 27,865,000 | 93,638,000 | — | -53,637,000 |
| Dec 2022 | 1,683,000 | -67,181,000 | -105,032,000 | 31,323,000 | 159,426,000 | — | -52,775,000 |
TTM Snapshot
Revenues TTM
—
NetIncome TTM
—
OpCashFlow TTM
—
Assets (Latest)
—
Forward EPS
$-0.07
Peers — same industry
| Ticker | Name | Market Cap | Last | Daily % |
|---|---|---|---|---|
| UPB | Upstream Bio, Inc. | $331.96M | $6.10 | — |
| IRD | Opus Genetics, Inc. | $333.57M | $4.04 | — |
| SCYX | SCYNEXIS INC | $336.04M | $4.23 | — |
| CATX | Perspective Therapeutics, Inc. | $336.44M | $2.95 | — |
| AMRN | AMARIN CORP PLC\UK | $319.57M | $15.24 | — |
News headlines (Yahoo Finance, 1h cache)
Northwest Biotherapeutics Appoints Dr. Annalisa Jenkins As Strategic Adviser To Advance Dendritic Cell Cancer Vaccine Platform
2026-04-30 16:30 · Yahoo
Northwest Biotherapeutics Announces Establishment Of the Company's Own Dedicated Leukapheresis Clinic
2026-04-21 13:30 · Yahoo
Northwest Biotherapeutics Announces That Construction Activities Are Under Way For the First Grade C Manufacturing Suite in the Sawston, UK Facility
2025-11-20 19:40 · Yahoo
Northwest Biotherapeutics: Q3 Earnings Snapshot
2025-11-14 22:47 · Yahoo
Northwest Biotherapeutics Announces That Its Acquisition of Advent BioServices Ltd. Has Closed
2025-10-24 16:03 · Yahoo
Northwest Biotherapeutics Announces Agreement to Acquire Advent BioServices Ltd.
2025-08-27 16:39 · Yahoo
Northwest Biotherapeutics Announces the Passing of Its Senior Vice President and General Counsel, Mr. Les Goldman
2025-08-18 16:37 · Yahoo
Northwest Biotherapeutics: Q2 Earnings Snapshot
2025-08-14 22:04 · Yahoo
Recent Insider Activity
No insider activity indexed for this ticker.